Preconcentration and SERS-based determination of infliximab in blood by using a TNF-α-modified gold-coated copper oxide nanomaterial
Author:
Publisher
Springer Science and Business Media LLC
Subject
Analytical Chemistry
Link
http://link.springer.com/content/pdf/10.1007/s00604-019-3947-y.pdf
Reference35 articles.
1. Lichtenstein GR (2013) Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response. Ther Adv Gastroenter 6:269–293
2. Kirman I, Whelan RL, Nielsen OH (2004) Infliximab: mechanism of action beyond TNF-α neutralization in inflammatory bowel disease. Eur J Gastroen Hepat 16:639–641
3. Elgundi Z, Reslan M, Cruz E, Sifniotis V, Kayser V (2017) The state-of-play and future of antibody therapeutics. Adv Drug Deliv Rev 122:2–19
4. Baert F, Noman M, Vermeire S, Van Assche G, D'haens G, Carbonez A, Rutgeerts P (2013) Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 348:601–608
5. Paul S, Moreau AC, Del Tedesco E, Rinaudo M, Phelip J-M, Genin C, Peyrin-Biroulet L, Roblin X (2014) Pharmacokinetics of adalimumab in inflammatory bowel diseases: a systematic review and meta-analysis. Inflamm Bowel Dis 20:1288–1295
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development and validation of enzyme-linked immunosorbent assays for the measurement of infliximab and anti-drug antibody levels;Heliyon;2023-11
2. Application of magnetic solid-phase extraction for sensitive determination of anticancer drugs in urine by means of diamino benzidine tetrachlorohydrate modified magnetic nanoparticles;Pharmacological Reports;2023-02-25
3. Towards Label-free detection of viral disease agents through their cell surface proteins: Rapid screening SARS-CoV-2 in biological specimens;SLAS Discovery;2022-09
4. Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban;Biomolecules;2022-04-17
5. Label-free identification of Erythropoietin isoforms by surface enhanced Raman spectroscopy;Talanta;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3